Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by Massachusetts General Hospital
Information provided by (Responsible Party):
John W. Denninger, MD, PhD, Massachusetts General Hospital Identifier:
First received: September 23, 2013
Last updated: October 22, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2018
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)